Sandrine Laboureau

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

S. Hescot, María Currás-Freixes, Timo Deutschbein et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 180 citations · Full text

Medicine, Oncology, Radiology +15

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

Frédéric Castinetti, Steven G. Waguespack, Andreas Machens et al. · The Lancet Diabetes & Endocrinology · 2019 · 149 citations · Full text

Medicine, Endocrinology, Oncology +11

Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes

Marie-Victoire Sénat, Hélène Affres, Alexandra Letourneau et al. · JAMA · 2018 · 127 citations · Full text

Public Health, Maternal Health, Obstetrics +14

Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma

Alexandre Buffet, Laurène Ben Aim, Sophie Leboulleux et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 123 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

Éric Baudin, Bernard Goichot, Alfredo Berruti et al. · The Lancet · 2024 · 66 citations · Full text

Medicine, Oncology, Pharmacology +7